The healthcare market has shown a significant increase in M&A activity since the start of April, with a total of 43 new deals recorded as of April 5th. The number of deals announced during the same period last year was lower at 38.
So far, the announced deals point to a notable trend towards eHealth, with nine deals announced so far this month, making up approximately 21% of deals. By comparison, there were eight eHealth deals announced during the same period last year.
Additionally, there has been an increase in Physician Medical Group deals, with 8 deals announced this year, compared to seven from last year. The specialties involved in these deals have also evolved, with a focus on internal medicine (two deals) and eye care (two deals) as key areas of consolidation.
The four Pharmaceutical deals announced, including a medical marijuana deal, also reflect the continued growth of this sector. In contrast, only one Pharmaceutical deal was announced in the same period in 2022.
Overall, the trends suggest a dynamic and evolving healthcare market with a focus on technology and consolidation in certain specialties. Additionally, the growth of the Pharmaceutical sector, including the medical marijuana deal, signals a shift towards alternative and innovative treatments.
